Atlas Biolabs | GenomeWeb

Atlas Biolabs

NEW YORK (GenomeWeb News) – German molecular genetics analysis firm Atlas Biolabs this week announced its participation in two European research projects directed at studying the impact of chromatin dynamics on DNA damage (aDDRess) and the effect of DNA damage on cellular aging (CodeAge).

NEW YORK (GenomeWeb News) – German molecular genetics analysis firm Atlas Biolabs today said that it has been accredited as a Certified Service Provider for Affymetrix's DMET Plus Solution.

Atlas Biolabs said this week that it has signed a collaborative agreement with Ingenuity Systems so that it can provide its customers with the option to analyze and interpret their study data with Ingenuity's products.

The company can now develop a software-based expert system for assessing chromosomal aberrations to complement its genotyping and molecular karyotyping services.

New Products

Premium

Atlas Biolabs offering Roche NimbleGen's SeqCap EZ enrichment, Sanger Institute's COSMIC 52

Atlas will process customer gDNA samples for genomic enrichment using the complete NimbleGen Sequence Capture Array and solution-based capture workflow.

Atlas will use the bioinformatics product with its DNA chip analysis offerings.

Berlin-based Atlas Biolabs recently became certified under Roche NimbleGen's service provider program. It will offer DNA capture services using NimbleGen arrays followed by sequencing on 454's GS FLX.

New Product Watch

Premium

Roche NimbleGen, Atlas Biolabs, Silicon Kinetics, Dimole

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.